OSTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
OS Therapies Inc (OSTX) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock shows weak technical indicators, no positive trading trends, and lacks significant catalysts or financial growth to justify a buy decision. The pre-market price increase of 5.11% is not supported by strong fundamentals or sentiment, making it a risky investment for long-term holding.
The technical indicators are bearish. The MACD is below 0 and negatively expanding, RSI is neutral at 33.286, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 1.475, with key support at 1.375 and resistance at 1.574. This suggests a weak price trend.
NULL identified. No recent news or significant events to drive positive sentiment.
Insiders are selling heavily, with a 100.96% increase in selling activity over the last month. Financial performance remains weak with no revenue growth and negative net income.
In Q3 2025, the company reported no revenue growth (0% YoY), a net loss of -$6,879,530 (up 139.27% YoY), and an EPS of -0.22 (up 57.14% YoY). Gross margin remains at 0%. The financials indicate no significant growth or profitability.
No analyst ratings or price target changes available for OSTX.
